BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$301.92 USD
+5.10 (1.72%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $302.11 +0.19 (0.06%) 4:32 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/1/24 |
---|---|
Current Quarter | 2.12 |
EPS Last Quarter | 2.29 |
Last EPS Surprise | 12.25% |
ABR | 2.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 10.80 |
Next Year | 11.75 |
EPS (TTM) | 10.72 |
P/E (F1) | 27.48 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 648.56M | 688.76M | 2.69B | 2.85B |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 649.70M | 693.50M | 2.70B | 2.86B |
Low Estimate | 647.41M | 684.02M | 2.68B | 2.84B |
Year ago Sales | 681.11M | 632.12M | 2.67B | 2.69B |
Year over Year Growth Est. | -4.78% | 8.96% | 0.66% | 6.00% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.12 | 2.84 | 10.80 | 11.75 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | 2.03 | 2.70 | 10.41 | 11.46 |
High Estimate | 2.20 | 2.98 | 11.19 | 12.04 |
Low Estimate | 2.03 | 2.70 | 10.41 | 11.46 |
Year ago EPS | 3.00 | 2.33 | 11.78 | 10.80 |
Year over Year Growth Est. | -29.33% | 21.89% | -8.32% | 8.80% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.12 | 2.84 | 10.80 | 11.75 |
7 Days Ago | 2.12 | 2.84 | 10.80 | 11.75 |
30 Days Ago | 2.12 | 2.84 | 10.80 | 11.75 |
60 Days Ago | 2.10 | 2.80 | 10.42 | 11.46 |
90 Days Ago | 2.10 | 2.80 | 10.42 | 11.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.12 | 2.84 | 10.80 | 11.75 |
Zacks Consensus Estimate | 2.12 | 2.84 | 10.80 | 11.75 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.29 | 3.10 | 2.33 | 3.00 | NA |
Estimate | 2.04 | 2.93 | 2.87 | 2.55 | NA |
Difference | 0.25 | 0.17 | -0.54 | 0.45 | 0.08 |
Surprise | 12.25% | 5.80% | -18.82% | 17.65% | 4.22% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more